COMMUNIQUÉS West-GlobeNewswire

INNATE PHARMA : IPH4102: Final results of the dose-escalation part of the Phase I study

16/10/2017 - 07:00

Final results of the dose-escalation part from the Phase I trial evaluating IPH4102 in patients with advanced cutaneous T-cell lymphomas presented at the EORTC CLTF meeting Marseille, France, October 16, 2017, 7:00 AM [...]

INNATE PHARMA : IPH4102: Résultats finaux de la partie escalade de dose de l'étude de Phase I

16/10/2017 - 07:00

Présentation des Résultats finaux de l'escalade de dose de l'essai de Phase I évaluant IPH4102 chez des patients atteints de lymphomes T cutanés avancés au congrès de l'EORTC CLTF Marseille, le 16 octobre 2017, 7h00 [...]

World Conference on Lung Cancer Sunday Press Conference: Introducing New Awards and Global Guidelines

15/10/2017 - 09:47

YOKOHAMA, Japan, Oct. 15, 2017 (GLOBE NEWSWIRE) -- The first press briefing at the International Association for the Study of Lung Cancer (IASLC) 18 th World Conference on Lung Cancer (WCLC) highlighted new awards and [...]

MITHRA ANNOUNCES COMPLETION OF RECRUITMENT IN DONESTA® PHASE II STUDY

13/10/2017 - 23:00

PRESS RELEASE MIThRA ANNOUNCES completion of recruitment in donesta® PhAse II study Donesta ® Phase II study remains on track to report top line data late Q1 2018 260 women recruited in total, of which 86 have already [...]

Medtronic and Mercy Announce Data Sharing Partnership to Accelerate Medical Device Innovation

13/10/2017 - 16:00

Real-World Clinical Data is Key to Creating More Effective Medical Devices and Enabling Better Patient Health DUBLIN and ST. LOUIS - October 13, 2017 - Medtronic plc (NYSE: MDT), the global leader in medical technology [...]

Novavax Announces Leadership Change

13/10/2017 - 13:30

GAITHERSBURG, Md., Oct. 13, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) announced today that Barclay A. "Buck" Phillips has submitted his resignation as Senior Vice President, Chief Financial Officer (CFO) and [...]

Inivata Collaborates with Genomics England to Assess Samples and Explore Potential of Liquid Biopsy to Improve Cancer Management and Patient Outcomes

13/10/2017 - 13:30

Inivata Collaborates with Genomics England to Assess Samples and Explore Potential of Liquid Biopsy to Improve Cancer Management and Patient Outcomes Pilot study to test Genomics England samples using Inivata's InVision [...]

Summit Therapeutics plc : Holding(s) in Company

13/10/2017 - 10:10

TR-1: S tandard form for notification of major holdings 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : Summit Therapeutics PLC Sedol BN40HZ0 1b. Please [...]

AroCell AB: announces that a distribution agreement has been signed with Pathway Diagnostics Ltd, for distribution of the AroCell TK 210 ELISA test in United Kingdom and Ireland.

13/10/2017 - 08:50

"We very much look forward to this new collaboration with the England based Pathway Diagnostics for the distribution of our TK 210 ELISA test", states Jan Stålemark, AroCell CEO. "Pathway Diagnostics Ltd is a leading [...]

Solon Eiendom ASA : Primary insider notification

13/10/2017 - 08:30

(Oslo, Norway, 12 October 2017) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Skøien AS) has today bought 35 000 shares in Solon Eiendom ASA at a price of NOK 18,4133. Following [...]

Nouveau logo, nouvelle charte, Medasys adopte une nouvelle identité visuelle

13/10/2017 - 08:30

Moderne et épurée, cette nouvelle charte, présentée dès le 13 octobre lors des JFR reflète pleinement la volonté du leader français d'intégration de SIH d'apporter une dimension dynamique et technologique à son identité [...]

Shire plc : New Formulation of ONCASPAR® (pegaspargase) Receives Positive CHMP Opinion in Europe for Patients with Acute Lymphoblastic Leukemia (ALL)

13/10/2017 - 08:04

New Formulation of ONCASPAR ® (pegaspargase) Receives Positive CHMP Opinion in Europe for Patients with Acute Lymphoblastic Leukemia (ALL) If approved, lyophilized formulation would offer three times longer shelf life [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

13/10/2017 - 07:00

REGULATED INFORMATION GHENT, Belgium, 13 October 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Bone Therapeutics SA : The preliminary documents for the Extraordinary General Shareholder Meeting on 30 October 2017 have been made available

13/10/2017 - 07:00

Regulated information The preliminary documents for the Extraordinary General Shareholder Meeting on 30 October 2017 have been made available Gosselies, Belgium, 13 October 2017, 7am CEST - BONE THERAPEUTICS (Euronext [...]

Bone Therapeutics SA : Mise à disposition des documents préparatoires à l'assemblée générale extraordinaire du 30 octobre 2017

13/10/2017 - 07:00

Information réglementée Mise à disposition des documents préparatoires à l'assemblée générale extraordinaire du 30 octobre 2017 Gosselies, Belgique, le 13 octobre 2017, 7h CEST - BONE THERAPEUTICS (code Euronext [...]

Medibio completes heavily oversubscribed institutional placement for $13.9 million to accelerate commercialisation

13/10/2017 - 04:00

Highlights: Placement completed, with oversubscriptions accepted up to $13.9 Million Fidelity Investments follows on to maintain 10.6% ownership of the Company IFM Investors and Regal FM to become substantial [...]

JFR 2017 - Medasys s'associe à Infinitt Healthcare pour répondre aux besoins de partage territoriaux de contenus cliniques et continuer la transformation des métiers en imagerie

12/10/2017 - 19:11

Anticipant la demande croissante de mobilité des professionnels de Santé en GHT ainsi que de Partage des Dossiers de Soins, Medasys organise une réponse complète aux différents besoins. Le leader français d'intégration [...]

ELSALYS BIOTECH acquires from JAZZ PHARMACEUTICALS the worldwide rights of LEUKOTAC®

12/10/2017 - 18:00

ELSALYS BIOTECH acquires from JAZZ PHARMACEUTICALS the worldwide rights of LEUKOTAC ® , an immunotherapy antibody with clinical benefits in s teroid-resistant acute Graft-versus-Host Disease In a recent clinical study, [...]

ELSALYS BIOTECH acquiert auprès de JAZZ PHARMACEUTICALS les droits mondiaux de LEUKOTAC®

12/10/2017 - 18:00

ELSALYS BIOTECH acquiert auprès de JAZZ PHARMACEUTICALS les droits mondiaux de LEUKOTAC ® , un anticorps d'immunothérapie porteur de bénéfices cliniques dans la maladie aigüe cortico-résistante du greffon contre l'hôte [...]